Thus, our results suggest that the abnormal regulation of NEIL1, NEIL2, and NEIL3 expression is involved in the development of cancer via an increase in the prevalence of somatic mutations, providing a new and important link between abnormalities in the DNA glycosylases NEIL1, NEIL2, and NEIL3 and human cancer. This evidence concerns the gene NEIL2 and cancer.